Multiple Class I Peptides & Montanide ISA 51 VG w Escalating Doses of Anti-PD-1 ab BMS936558

This study is currently recruiting participants.
Verified February 2014 by H. Lee Moffitt Cancer Center and Research Institute
Sponsor:
Collaborators:
Bristol-Myers Squibb
Medarex
Information provided by (Responsible Party):
H. Lee Moffitt Cancer Center and Research Institute
ClinicalTrials.gov Identifier:
NCT01176461
First received: August 5, 2010
Last updated: February 13, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)
No publications provided by H. Lee Moffitt Cancer Center and Research Institute

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):